Skip to main content
Caplight Logo









Panaxium

Panaxium

Private
Aix-en-ProvenceHealthcare & Life Scienceshttps://panaxium.com/

Last Round

Grant

Nov 28, 2025

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Panaxium is a bioelectronic medicine company that develops AI-enabled iontronic neurostimulation therapies and medical equipment to treat brain injuries and restore motor function.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

brain-machine interfaceBMIneurostimulationiontronicclosed-loop neurostimulationneural implantsbrain-computer interfaceBCIbioelectronic medicineneuro-injury assessmentmedical AIbioelectronicsadaptive stimulationneuromodulationbiocompatible materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Panaxium Comparables

Compare Panaxium with similar companies based on industry and business-model similarity.

Panaxium comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neurosoft Bioelectronics
81%
Precision Neuroscience
75%
Motif Neurotech
73%

Panaxium Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 28, 2025
SeedApr 10, 2023

Key People

Founding team and executive leadership

Jonathan Balfour

COO CFO

Executive Team

Panaxium Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 182% MoM.

  • Jul 28, 2026

    Monthly visitors grew 361% MoM, from 82 to 378.

Panaxium Filings

Explore SEC and related filing metadata, where available.

Panaxium filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Panaxium's valuation, stock price, and market status.

Is Panaxium a public or private company?

Panaxium is a private company.

What is the current stock price of Panaxium?

Panaxium is a private company with no public stock price. No recent secondary market data is available.

How much is Panaxium worth (valuation)?

Valuation information for Panaxium is not publicly available.

Can I buy Panaxium stock?

Panaxium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Panaxium's last funding round?

Panaxium's most recent funding round was Grant on November 28, 2025.

Who are the main investors in Panaxium?

Key investors in Panaxium include Ontario Brain Institute, Centre for Aging and Brain Health Innovation.

Will Panaxium IPO soon?

No public IPO plans have been announced for Panaxium.

How can I track Panaxium secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panaxium's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAix-en-Provence
Employee Range11
Year Founded2016
Last FundingNov 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?